Searched for
RANBAXY LIMITED DISPUTE
Pitiless Cut: Johnson & Johnson’s broken hip implants and the cost of corporate negligenceIndia's Supreme Court has ordered Johnson & Johnson to pay more compensation for faulty hip implants. This decision comes after a long lega...- Fortis Open Offer: Daiichi Sankyo's 'misleading' statements continue to damage interests, says NTKIHH Healthcare's subsidiary, NTK, accuses Daiichi Sankyo of damaging its interests through misleading statements regarding the Fortis Healt...
- Buying house jointly, being a guarantor, dealing with inheritance: How children can fix money problemsWhether it is buying a house jointly, being a guarantor, investing in your sibling’s business, or dealing with inheritance, find out the qu...
- Stocks in the news: TCS, Infosys, Jet Airways, GVK Infra and IDBI BankDepartment of Telecom has given approval for the merger of Tata Teleservices (TTSL) with Bharti Airtel.
- Top stocks in focus on 13 October 2017Here is a list of top stocks that are likely to be in focus in today's trading session.
- Ranbaxy's Singh brothers must seek permission to sell assets: High CourtThey have been directed to furnish details of assets to ascertain that they will have enough funds to cover an arbitration award granted to...
- Should investors purchase these beaten-down stocks?Investors should also examine aspects like business prospects, management quality and valuation before betting on a stock.
- Sensex slips over 100 points, Nifty slips below 8700 ahead of FOMC outcome; ten stocks in focusThe 30-stock Sensex was trading in a range ahead of FOMC meet. Sesa Sterlite was top gainer with 3% gains. NTPC cracked 4%.
- Sun shines in pharma space; M-cap greater than DRL, Lupin, Cipla & Ranbaxy combinedThe market capitalisation of Sun Pharmaceuticals exceeded that of Dr Reddy's, Lupin, Cipal and Ranbaxy Laboratories combined on Wednesday, ...
- Ten stocks in focus in Tuesday morning tradeIndian markets are expected to trade in a range. Here is a list of ten stocks which are likely to be in focus in trade today.
- RIL, IGL, MCX, Wockhardt & Ranbaxy under scanner: Will it impact stock performance?Some have come under the lens of regulatory bodies for supposed transgressions, while others have sufferred due to policies or government o...
- Supreme Court seeks report on Zenotech's complaint against Ranbaxy, DaiichiThe SC has sought a status report on a complaint filed by Zenotech Labs, which accused officials of Ranbaxy and Daiichi of criminal breach ...
- EC fines Ranbaxy, others for blocking cheaper drugsEC imposed a fine of 146 million euros on nine pharma companies, including Ranbaxy Laboratories, for delaying market entry of cheaper gener...
- Ranbaxy recalls generic Lipitor from the US marketRanbaxy today said it is recalling its generic version of cholesterol-lowering drug Lipitor from US market leading to temporary disruption ...
- Stocks to watch: RIL, Tata Motors, Cipla, RanbaxyEquities are likely to fall further on Friday in tandem with negative global cues. However, losses could be limited after inflation cooled ...
- Ambanis may be at war, but not their staffWhile the war between the Ambani brothers is showing no signs of ceasing, some staffers of the two rivals still share office space. Success...
- Gujarat HC stays NPPA order to cut price of Cadila drug EnvasThe Gujarat HC has stayed a decision of the drug price regulator National Pharmaceutical Pricing Authority to lower the price of Ahmedabad-...
- Generic firms & innovators tie up to cut legal costsIn these settlements, the generic company typically agrees to delay its entrance in the market in exchange for certain benefits. Lifestyle ...
Load More
